1. Home
  2. BKYI vs ARTL Comparison

BKYI vs ARTL Comparison

Compare BKYI & ARTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BKYI
  • ARTL
  • Stock Information
  • Founded
  • BKYI 1993
  • ARTL 2011
  • Country
  • BKYI United States
  • ARTL United States
  • Employees
  • BKYI N/A
  • ARTL N/A
  • Industry
  • BKYI Computer Software: Prepackaged Software
  • ARTL Biotechnology: Pharmaceutical Preparations
  • Sector
  • BKYI Technology
  • ARTL Health Care
  • Exchange
  • BKYI Nasdaq
  • ARTL Nasdaq
  • Market Cap
  • BKYI 2.7M
  • ARTL 3.3M
  • IPO Year
  • BKYI 1997
  • ARTL N/A
  • Fundamental
  • Price
  • BKYI $0.79
  • ARTL $1.02
  • Analyst Decision
  • BKYI
  • ARTL
  • Analyst Count
  • BKYI 0
  • ARTL 0
  • Target Price
  • BKYI N/A
  • ARTL N/A
  • AVG Volume (30 Days)
  • BKYI 234.7K
  • ARTL 1.2M
  • Earning Date
  • BKYI 06-13-2025
  • ARTL 05-16-2025
  • Dividend Yield
  • BKYI N/A
  • ARTL N/A
  • EPS Growth
  • BKYI N/A
  • ARTL N/A
  • EPS
  • BKYI N/A
  • ARTL N/A
  • Revenue
  • BKYI $6,929,571.00
  • ARTL N/A
  • Revenue This Year
  • BKYI $25.12
  • ARTL N/A
  • Revenue Next Year
  • BKYI N/A
  • ARTL N/A
  • P/E Ratio
  • BKYI N/A
  • ARTL N/A
  • Revenue Growth
  • BKYI N/A
  • ARTL N/A
  • 52 Week Low
  • BKYI $0.52
  • ARTL $0.82
  • 52 Week High
  • BKYI $3.68
  • ARTL $1.59
  • Technical
  • Relative Strength Index (RSI)
  • BKYI 48.49
  • ARTL 52.13
  • Support Level
  • BKYI $0.74
  • ARTL $0.99
  • Resistance Level
  • BKYI $0.96
  • ARTL $1.05
  • Average True Range (ATR)
  • BKYI 0.08
  • ARTL 0.07
  • MACD
  • BKYI 0.01
  • ARTL 0.00
  • Stochastic Oscillator
  • BKYI 41.38
  • ARTL 30.00

About BKYI BIO-key International Inc.

BIO-key International Inc is a fingerprint biometric technology company. It develops and markets fingerprint biometric identification and identity verification technologies, as well as related identity management and credentialing hardware and software solutions. Its product portfolio comprises SideSwipe, SidePass, EcoID, WEB-key, and others. The company generates its revenue in the form of Services, License fees, and others.

About ARTL Artelo Biosciences Inc.

Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.

Share on Social Networks: